journal article·2026-07-25

Gentamicin‐Linked Supramolecular Hybrid Hydrogels: Mechanically Robust Cucurbit[7]Uril‐Based Networks for Prolonged Infection Control

A. Aslihan Gokaltun, Dinesh Shrestha, Carolina Dos Anjos, Nafiseh Khoshnevisan, Tianhong Dai, Ayse Asatekin, O. Berk Usta

Publisher page

Abstract

ABSTRACT Burn wound infections, caused by Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) , remain a major clinical challenge, delaying healing and increasing the risk of mortality. Gentamicin sulfate (GEN) is a broad‐spectrum antibiotic widely used for infection control. However, conventional GEN‐loaded hydrogels often suffer from burst release and inadequate mechanical strength for sustained wound coverage. Here, we report GEN‐loaded (0.11–0.72 w/v%) supramolecular hybrid hydrogels (GEN‐SHHs) in which GEN acts in a dual role as both an antimicrobial and a dynamic physical crosslinker through cucurbit[7]uril (CB[7]) host–guest interactions within a clay‐reinforced hydrogel network. This polymer network gels within 5 s and achieves an exceptional elastic modulus (up to ∼270 kPa), the highest reported for CB[7]‐based or antibiotic‐crosslinked hydrogels. This integrated design achieves sustained GEN release for 14 days at concentrations above the minimum inhibitory and bactericidal thresholds for S. aureus and P. aeruginosa , yielding complete eradication (>99.999%) at GEN loadings ≥0.44 w/v%. Prolonged antimicrobial efficacy is further confirmed by persistent inhibition zones over two weeks. GEN‐SHHs also maintain high cytocompatibility (>94% viability) with human dermal fibroblasts (HDFs) and epidermal keratinocytes (HEKs). These results establish GEN‑SHHs combining dynamic bonding, high stiffness, and durable antimicrobial performance for advanced infection‐resistant wound dressings.
Source: crossref · Quality: baseline

Research context

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center For Engineering in Medicine and Surgery, Massachusetts General Hospital, Department of Surgery Harvard Medical School Boston Massachusetts USA

Shriners Children's Boston Boston Massachusetts USA

Department of Chemical and Biological Engineering Tufts University Medford Massachusetts USA

Wellman Center for Photomedicine, Massachusetts General Hospital, Department of Dermatology Harvard Medical School Boston Massachusetts USA

Funding

National Institutes of Health · National Science Foundation

References (57)

Show source-provided references
1. 10.3390/medicina5808106610.3390/medicina58081066 ↗
2. Cambiaso‐Daniel J. · 2018 · 9310.1016/B978-0-323-47661-4.00011-3 ↗
3. 10.1111/iwj.1399810.1111/iwj.13998 ↗
4. 10.3389/fbioe.2021.78846110.3389/fbioe.2021.788461 ↗
5. 10.1089/wound.2019.101810.1089/wound.2019.1018 ↗
6. 10.1007/s40262‐022‐01143‐010.1007/s40262‐022‐01143‐0 ↗
7. 10.1016/j.mtbio.2022.10049910.1016/j.mtbio.2022.100499 ↗
8. 10.1093/burnst/tkac04710.1093/burnst/tkac047 ↗
9. 10.1021/acsabm.2c0064710.1021/acsabm.2c00647 ↗
10. 10.1021/acsapm.2c0219610.1021/acsapm.2c02196 ↗
11. 10.1208/s12249‐010‐9474‐010.1208/s12249‐010‐9474‐0 ↗
12. 10.1021/acs.chemrev.5b0029910.1021/acs.chemrev.5b00299 ↗
13. 10.1016/j.cis.2023.10300010.1016/j.cis.2023.103000 ↗
14. 10.1002/adma.20180509210.1002/adma.201805092 ↗
15. 10.1155/2023/710976610.1155/2023/7109766 ↗
16. 10.1039/D1TB02761A10.1039/D1TB02761A ↗
17. 10.3390/md1805023310.3390/md18050233 ↗
18. 10.1021/acs.chemrev.0c0108810.1021/acs.chemrev.0c01088 ↗
19. 10.1002/adhm.20220090210.1002/adhm.202200902 ↗
20. 10.1039/c4cs00273c10.1039/c4cs00273c ↗
21. Supramolecular Hybrid Hydrogels as Rapidly on‐demand Dissoluble, Self‐healing, and Biocompatible Burn Dressings
22. 10.1038/nature0869310.1038/nature08693 ↗
23. Nanocomposite Hydrogels: A Unique Organic–inorganic Network Structure With Extraordinary Mechanical, Optical, and Swelling/De‐swelling Properties10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9 ↗
24. 10.1002/adfm.20160437910.1002/adfm.201604379 ↗
25. 10.1021/acsapm.5c0427410.1021/acsapm.5c04274 ↗
26. Cinnamaldehyde–cucurbituril Complex: Investigation of Loading Efficiency and Its Role in Enhancing Cinnamaldehyde in Vitro Anti‐tumor Activity10.1039/D2RA00044J ↗
27. Contrasting p K a Shifts in Cucurbit [7]Uril Host–Guest Complexes Governed by an Interplay of Hydrophobic Effects and Electrostatic Interactions10.1021/acsomega.6b00427 ↗
28. 10.1016/j.carres.2003.08.00510.1016/j.carres.2003.08.005 ↗
29. Differences in Cucurbit [7]Uril: Surfactant Complexation Promoted by the Cationic Head Group10.1002/cplu.201300164 ↗
30. 10.1039/C7RA08865E10.1039/C7RA08865E ↗
31. 10.1002/advs.20180023110.1002/advs.201800231 ↗
32. 10.3390/pharmaceutics1212118810.3390/pharmaceutics12121188 ↗
33. 10.1016/j.biomaterials.2010.04.01110.1016/j.biomaterials.2010.04.011 ↗
34. 10.1016/S0142‐9612(03)00466‐610.1016/S0142‐9612(03)00466‐6 ↗
35. 10.1016/j.jddst.2022.10407810.1016/j.jddst.2022.104078 ↗
36. 10.1038/natrevmats.2016.7110.1038/natrevmats.2016.71 ↗
37. 10.1016/S1773‐2247(13)50094‐310.1016/S1773‐2247(13)50094‐3 ↗
38. 10.3390/polym907028610.3390/polym9070286 ↗
39. 10.1016/j.apm.2022.08.00810.1016/j.apm.2022.08.008 ↗
40. 10.1002/advs.20230948210.1002/advs.202309482 ↗
41. 10.1128/spectrum.00495‐2410.1128/spectrum.00495‐24 ↗
42. 10.1111/1751‐7915.7017410.1111/1751‐7915.70174 ↗
43. 10.1073/pnas.210764411810.1073/pnas.2107644118 ↗
44. 10.2165/11317030‐000000000‐0000010.2165/11317030‐000000000‐00000 ↗
45. 10.3389/fmicb.2012.0040810.3389/fmicb.2012.00408 ↗
46. 10.1016/j.bioflm.2021.10005610.1016/j.bioflm.2021.100056 ↗
47. 10.1128/aac10.1128/aac ↗
48. 10.1111/1751‐7915.1448710.1111/1751‐7915.14487 ↗
49. 10.1016/j.jpedsurg.2018.06.01110.1016/j.jpedsurg.2018.06.011 ↗
50. 10.1080/14787210.2022.204479510.1080/14787210.2022.2044795 ↗
51. 10.3390/ijms2301040110.3390/ijms23010401 ↗
52. 10.1097/00005373‐199106000‐0000710.1097/00005373‐199106000‐00007 ↗
53. Comparative Study of Sisomicin and Gentamycin Action on the Cells in a Tissue Culture
54. Comparison of Primary human Fibroblasts and Keratinocytes With Immortalized Cell Lines Regarding Their Sensitivity to Sodium Dodecyl Sulfate in a Neutral Red Uptake Cytotoxicity Assay
55. Clinical Pharmacology of Gentamicin
56. P.Wayne “Clinical and Laboratory Standards Institute (CLSI) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically ”Approved Standard Clinical and Laboratory Standards Institute (CLSI) Methods29(2009):M07–A8.
57. 10.2144/97234bm2210.2144/97234bm22 ↗